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Abstract
Background: Overall expression of neurotrophins in the respiratory tract is upregulated in infants infected by the respiratory
syncytial virus (RSV), but it is unclear where (structural vs. inflammatory cells, upper vs. lower airways) and why, these
changes occur. We analyzed systematically the expression of neurotrophic factors and receptors following RSV infection of
human nasal, tracheal, and bronchial epithelial cells, and tested the hypothesis that neurotrophins work as innate survival
factors for infected respiratory epithelia.
Methodology: Expression of neurotrophic factors (nerve growth factor, NGF; brain-derived neurotrophic factor, BDNF) and
receptors (trkA, trkB, p75) was analyzed at the protein level by immunofluorescence and flow cytometry and at the mRNA
level by real-time PCR. Targeted siRNA was utilized to blunt NGF expression, and its effect on virus-induced apoptosis/
necrosis was evaluated by flow cytometry following annexin V/7-AAD staining.
Principal Findings: RSV infection was more efficient in cells from more distal (bronchial) vs. more proximal origin. In
bronchial cells, RSV infection induced transcript and protein overexpression of NGF and its high-affinity receptor trkA, with
concomitant downregulation of the low-affinity p75
NTR. In contrast, tracheal cells exhibited an increase in BDNF, trkA and
trkB, and nasal cells increased only trkA. RSV-infected bronchial cells transfected with NGF-specific siRNA exhibited
decreased trkA and increased p75
NTR expression. Furthermore, the survival of bronchial epithelial cells was dramatically
decreased when their endogenous NGF supply was depleted prior to RSV infection.
Conclusions/Significance: RSV infection of the distal airway epithelium, but not of the more proximal sections, results in
overexpression of NGF and its trkA receptor, while the other p75
NTR receptor is markedly downregulated. This pattern of
neurotrophin expression confers protection against virus-induced apoptosis, and its inhibition amplifies programmed cell
death in the infected bronchial epithelium. Thus, pharmacologic modulation of NGF expression may offer a promising new
approach for management of common respiratory infections.
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Introduction
The most common agent of lower respiratory infections in early
childhood is respiratory syncytial virus (RSV) [1,2,3]. In addition to the
significant morbidity and mortality caused by the acute infection [4], a
large proportion of these young patients continue to have recurrent
post-bronchiolitis episodes of lower airway obstruction, which may
continue for years after the acute infection has resolved [4,5,6]. More
recently, RSV has been shown to be a significant cause of respiratory
illness among elderly and high-risk adults [7], and studies in patients
with chronic obstructive pulmonary disease (COPD) have raised the
possibility of persistent low-grade RSV infection in this population [8].
Studies conducted in animal models have shown that RSV
infection increases the expression of critical neurotrophic growth
factors and receptorsin the lungs,and that the consequent changes in
airway neuro-immunomodulation play an important role in the
pathophysiology of airway inflammation and hyperreactivity during
and after the acute infection [9]. We have recently confirmed these
findings in humans, showing increased concentrations of nerve
growth factor (NGF), brain-derived neurotrophic factor (BDNF), and
the receptor tropomyosin-related kinase A (trkA) in the cell fractions
obtained by bronchoalveolar lavage from infants with RSV infection
[10]. However, we were unable to define whether the source of these
factors was in infected proximal or distal structural cells, or
inflammatory cells recruited and stimulated by the virus. Also, the
exact role played by neurotrophins in inflammatory conditions has
not been established conclusively, and there is circumstantial
evidence supporting both protective and pathologic effects [2,11,12].
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6444Although multiple cell types are involved in the pathogenesis of
RSV disease [13], the respiratory epithelium is unanimously
believed to be the primary target of the infection and plays a
central role in airway injury and remodeling by releasing
inflammatory and growth factors capable of modulating immune
and reparative processes [14,15,16]. It is common knowledge that
naturally occurring RSV infections in humans initiate in the nasal
region, and in young children frequently spread through the
trachea and finally establish in the bronchial tree. The individual
cellular responses to RSV may differ both quantitatively and
qualitatively among different anatomical regions of the respiratory
system, but specific information is difficult to obtain because most
clinical data are derived from lavage samples collected from the
upper [17] or lower airways [10] of RSV-infected patients,
therefore pooling together information from different sections of
the respiratory tract and bypassing others.
Thus, in this study we evaluated human cell lines deriving from
nasal, tracheal or bronchial epithelium, studied their individual
susceptibility to RSV infection, and systematically quantified the
effects of the infection on the transcript and protein expression of
different neurotrophic factors and receptors by immunocytochem-
istry, flow cytometry, and real-time PCR. Extending these studies,
we also explored the functional consequences of selective NGF
knock-out by siRNA in infected respiratory epithelia, and
specifically tested the hypothesis that this neurotrophin contributes
to an innate survival strategy deployed by cells being infected
against the invading virus, thereby modulating the pathological
and clinical manifestations of the infection.
Methods
Virus
RSV derived from RSV-A2 expressing the gene for green
fluorescent protein (rgRSV) was a kind gift of Dr. Mark E. Peeples
(Columbus Children Research Institute, Columbus, OH) and Dr.
Peter Collins (National Institutes of Health, Bethesda, MD).
Cultivation and harvesting of rgRSV was performed as described
previously. Briefly, virus was serially diluted and added to HEp-2
cell monolayers in 96 well-plates. Cells were incubated for 22 h
and green cells were counted by fluorescent microscopy. RSV titer
was determined in a modified plaque-forming unit (PFU) assay,
and was calculated as follows: (number of infectious units)6(in-
verse of dilution)/(volume of inoculum). The stock titer of the virus
pool used in the current study was 4.7610
6 PFU/ml. To confirm
that the observed effects were caused by actively replicating virus
and not by exposure to constituents of the virion or culture
medium, selected experiments were performed using aliquots of
rgRSV irradiated with a UV light source for 20 min to inactivate
the viral nucleic acid [18].
Cell lines
Human nasal, tracheal, and bronchial epithelial cells from
multiple donors were purchased from PromoCell (Heidelberg,
Germany) and were maintained in the recommended media and
supplements provided by the vendor. Each experiment was
repeated using cells from different donors throughout the study
to control for host genetics and environment. The number of
passage times for each airway section was matched in each
experiment and it never exceeded 5 passages. As 100% confluency
alters the cells morphology, we performed our experiments in cells
that were 70–80% confluent at the time of the infection with
rgRSV at MOI (multiplicity of infection) ranging from 1 to 10.
Virus multiplication was periodically monitored using a florescent
microscope.
FACS analysis
Nasal, tracheal and bronchial epithelial cells were grown to
confluency in a 6-well plate and were infected with rgRSV at
1 MOI. After 48 h of infection, cells were isolated by trypsiniza-
tion and were stained for intracellular and surface detection of
NGF, BDNF and their receptors trkA, trkB, and p75
NTR. TrkB
and p75
NTR antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). TrkA and isotype control goat
IgG conjugated with allophycocyanin (APC) were obtained from
R&D Systems (Minneapolis, MN). The additional isotype control
rabbit IgG was purchased from Southern Biotechnology (Birming-
ham, AL). We used antibodies conjugated with APC or
phycoerythrin (PE) because the virus was labeled with green
fluorescent protein (GFP). For cell death analysis, gating was
adjusted using cyanine 3 (Cy3) or 7-aminoactinomycin D (7-AAD)
staining with dot plots displaying FL3-7-AAD on the y-axis and
FL2-Cy3 on the x-axis, and 10,000 events were collected for each
sample. The five parameters simultaneously collected were linear
forward-angle light scatter (FSC), linear side scatter (SSC), log
FITC, log Cy3, and log 7-AAD. Data were acquired using a
FACSCalibur flow cytometer with Cell Quest Pro software (BD
Biosciences, Franklin Lakes, NJ) and were analyzed with Windows
Multiple Document Interface (WinMDI) software for flow
cytometry version 2.9 (The Scripps Research Institute, La Jolla,
CA).
Immunofluorescence
Nasal, tracheal and bronchial epithelial cells were grown to 70–
80% confluence on glass coverslips in a 6-well plate and infected
with 1 MOI of rgRSV for 48 h. Following treatment, cells were
rinsed in phosphate-buffered saline (PBS) and fixed in 4%
formaldehyde at room temperature for 10 minutes. Permeabiliza-
tion of cells was obtained with 0.5% Triton X-100 for 20 minutes.
Nonspecific antibody binding was blocked by incubation for 20
minutes in 16PBS/5% BSA. The coverslips were stained for 1 h
with anti-human NGF antibody (Santa Cruz Biotechnology) in
PBS/5% BSA or with the corresponding control isotype, followed
by Alexa Fluor 555 donkey anti-rabbit antibody (Invitrogen,
Carlsbad, CA) for another hour. The nuclei were stained with
TOPRO-3 (Invitrogen). Coverslips were inverted on slides and
mounted with Prolong Gold anti-fade reagent (Invitrogen). Images
were obtained using a Zeiss LSM510 confocal microscope with an
AxioImager Z1 system (Carl Zeiss, Jena, Germany). The FITC
(488 nm) channel was used to observe the GFP protein expressed
by rgRSV-infected cells.
Real-time PCR analysis
Total RNA was isolated using an RNeasy kit following the
manufacturer’s recommendations (Qiagen Inc., Valencia, CA).
Total RNA (1 mg) was used as template for cDNA synthesis
(Applied Biosystems, Foster City, CA) and the cDNAs were used for
quantitative real-time PCR analysis using SYBR green master mix
(Applied Biosystems) with an ABI 7500 real-time cycler (Applied
Biosystems). NGF, BDNF, trkA, trkB and p75
NTR primers were
purchased from SuperArray (Rockville, MD). RSV primers specific
for an 82-bp fragment of the viral nucleocapsid protein (sense:
GCTCTTAGCAAAGTCAAGTTGAATGA; anti-sense:
TGCTCCGTTGGATGGTGTATT) were purchased from Invi-
trogen. Hypoxanthine phosphoribosyltransferase 1 (HPRT1) was
used as housekeeping gene for transcripts normalization and
amplified with primers purchased from RealTimePrimers (Elkins
Park, PA). Relative changes in gene expression were calculated with
the following formula: fold change=2ˆ2(ddCt)=2-dCt (treated
NGF in RSV-Infected Cells
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e)2Ct (HPRT1) and Ct is the threshold number.
NGF knock-down by siRNA
The interactions between NGF and the other neurotrophic
factors and receptors during rgRSV infection were investigated by
silencing its expression in epithelial cells with a specific siRNA
(Dharmacon, Chicago, IL). Exponentially growing cells were
transiently transfected with either 50 mM of NGF siRNA or the
scrambledsiRNAcontrolusingLipofectamine2000
TM(Invitrogen).
Transfected cellsweremonitoredbyreal-timePCRforinterleukin 6
(IL-6) gene expression (SuperArray), which is commonly used to
rule out innate inflammatory activity triggered by double-stranded
RNA in mammalian systems [19]. Forty-eight hours following
transfection, cells were infected with 1 MOI of rgRSV for an
additional 24 h. Following virus challenge, cells were collected by
trypsinization and the pellet was used for RNA extraction.
Cell death analysis
To evaluate whether NGF plays a role in the survival of epithelial
cells during RSV infection, bronchial cells were treated with NGF
siRNA or with the control scrambled siRNA for 48–60 h and the
efficiency of NGF knock-down was monitored by real-time PCR
analysis. NGF-deficient bronchial epithelial cells were infected with
1 or 5 MOI of rgRSV. After 24 h infection, cells were harvested,
washed twice with PBS and counted using the trypan blue method
for viability. Subsequently, cells were re-suspended in 500 mlo f1 6
annexin buffer and stained with 1 ml of annexin V-PE (MBL,
Woburn, MA) for 10 min. In separate experiments, cells were
treated with both 7-AAD (Enzo Life Sciences, Farmingdale, NY), a
fluorescent intercalating dye that allows DNA quantitation, and
annexin V-Cy3 for 15 min. After fixation with 1% paraformalde-
hyde, 500 mlo f1 6annexin buffer were added to each sample and
fluorescence flow cytometric analyses were performed using a BD
Biosciences FACSCaliber instrument.
Statistical analysis
Data are expressed as mean6SEM. Geometric mean fluorescent
intensity (MFI) was calculated from the flow cytometry measure-
ments obtained in 3 or 4 independent experiments. PCR data are
the average of 3 or 4 independent experiments performed in
duplicate.Paired Student’st test [20] wasused toanalyzedifferences
between rgRSV-infected or UV-RSV-exposed cells and virus-free
controls. Differences between NGF-specific vs. scrambled siRNA
and apoptosis vs. necrosis were analyzed by ANOVA [21] and post-
hoc pairwise comparisons between means [22] were performed
using theHolm-Sidak method ortheSheffe’s test.Statistical analysis
was performed using the software SigmaStat version 3.5 (Systat
Software, Point Richmond, CA) and StatView version 5.0.1 (SAS
Institute, Cary, NC, USA) for Windows. Differences having a p
value,0.05 were considered significant.
Results
We quantified the susceptibility of human-derived nasal, tracheal
and bronchial epithelial cells to infection by recombinant human
RSV expressing green fluorescent protein (rgRSV). As shown in
Figure 1A, after incubation with rgRSV at 1 MOI for 48 h the
efficiency of infection was significantly different among cell lines,
with bronchial cells showing the highest infection rate compared to
tracheal cells (p,0.001) and nasal cells (p,0.001). No significant
difference was found between tracheal and nasal cells (p=0.14).
Immunocytochemical analysis showed sharply increased NGF
expression in rgRSV-infected bronchial epithelial cell cultures
(Figure 2A), with non-infected cells having virtually undetectable
NGF expression at baseline. Importantly, there was no visible
change in immunoreactivity for NGF in rgRSV-infected nasal and
tracheal cells compared to their non-infected controls (data not
shown). Furthermore, NGF expression appeared strongly upregu-
lated in infected bronchial cells with faint GFP staining, suggesting
either a paracrine effect or NGF amplification even at low levels of
viral replication. To quantitate the changes in protein expression,
rgRSV-infected cells were stained for NGF and analyzed by FACS
(Figure 2B and 2C). Again, bronchial epithelial cells infected with
rgRSV expressed higher NGF protein levels than the non-infected
control cells (p,0.01). Surprisingly, nasal epithelial cells infected
by rgRSV showed a decrease in NGF expression (p,0.01),
whereas tracheal cells showed no change compared to the non-
infected control cells (p=0.27).
Airway epithelial cells exposed to 1, 5, or 10 MOI of UV-
inactivated rgRSV did not show any significant change in NGF
expression compared to non-infected controls, indicating that
neurotrophin upregulation requires active viral replication.
Figure 3 shows the data obtained with the highest inoculum
(10 MOI), which had no significant effect on NGF expression in
nasal (p=0.08), tracheal (p=0.39), or bronchial (p=0.11) cells.
To analyze the effect of RSV infection on the expression of the
other neurotrophic factor BDNF, and of the neurotrophin
receptors trkA, trkB, and p75
NTR, we performed FACS analysis
using specific antibodies. Data presented in Figure 4A show
significant induction of the high-affinity NGF receptor trkA
(p,0.001) in nasal epithelial cells infected by rgRSV, combined
with downregulation of BDNF (p,0.05), its high-affinity receptor
trkB (p,0.05), and the low-affinity pan-neurotrophin receptor
p75
NTR (p,0.05). Tracheal epithelial cells (Figure 4B) exhibited
an increased expression of trkA (p,0.05), BDNF (p,0.01) and
trkB (p,0.001), but again with lower levels of p75
NTR (p,0.01).
TrkA and trkB receptors were significantly upregulated (p,0.01)
in rgRSV-infected bronchial cells (Figure 4C), but the p75
NTR
receptor was significantly downregulated (p,0.01) in these cells as
well. Overall, rgRSV consistently modified the pattern of NGF
receptors expression in the airways, increasing the high-affinity
trkA while decreasing the low-affinity p75
NTR, whereas the effect
on BDNF and its trkB receptor was generally smaller and more
variable.
Next, we analyzed whether protein expression was concordant
with transcript levels in these cell lines following rgRSV infection.
Real-time PCR analysis showed good correlation between mRNA
and protein expression of NGF and trkA. Nasal cells (Figure 5A)
infected with rgRSV did not exhibit any significant change in the
transcripts of neurotrophic factors and receptors, with the
exception of trkA that increased 8 fold over the non-infected
controls (p,0.01). In tracheal cells (Figure 5B), both BDNF
(p,0.01) and its receptor trkB (p,0.01) were significantly
upregulated by rgRSV infection, along with the increase in trkA
(p,0.01) and without change in p75
NTR levels. NGF was
significantly upregulated (p,0.01) in rgRSV-infected bronchial
cells (Figure 5C), together with a 9-fold increase in trkA (p,0.01).
Also, bronchial cells uniquely showed significant downregulation
of p75
NTR transcript (p,0.01) following rgRSV infection,
consistent with the protein results.
To investigate the role of NGF in modulating the signaling of
neurotrophic factors and their cognate receptors, non-infected or
rgRSV-infected epithelial cells were transfected with scrambled
control siRNA or NGF-specific siRNA. As shown in Figure 6, non-
infected nasal, tracheal and bronchial cells transfected with
scrambled siRNA did not show any change in neurotrophin gene
expression compared to non-transfected non-infected cells.
NGF in RSV-Infected Cells
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siRNA did not cause significant changes compared to non-
transfected infected cells. Also, transfection of epithelial cells with
either scrambled (p=0.47) or NGF-specific siRNA (p=0.16) did
not induce IL-6 mRNA expression (data not shown). NGF knock-
down by siRNA was efficient (70–90%) and highly statistically
significant (p,0.001) in all three cell lines evaluated, and affected
the expression of other neurotrophic factors and receptors during
rgRSV infection. In particular, NGF depletion in bronchial cells
reversed the effects of rgRSV on both its high-affinity receptor
trkA (p,0.001) and low-affinity receptor p75
NTR (p,0.001).
On the basis of these results, we assessed whether the depletion
of NGF induced by RNA interference, and the consequent
overexpression of p75
NTR receptors, trigger apoptosis in RSV-
infected bronchial epithelial cells, which had shown the highest
susceptibility to RSV infection and are the natural target of clinical
RSV disease. To this end, extensive FACS analysis and
immunocytochemical studies were performed, and results ob-
tained by annexin V-PE staining (Figure 7) indicated that early
markers of programmed cell death are detected in human-derived
bronchial epithelial cells subsequent to rgRSV exposure and that
selective NGF knock-down via siRNA enhances dramatically
apoptotic death driven by rgRSV infection (p,0.01).
We also compared the effects NGF depletion on necrosis vs.
apoptosis in rgRSV-infected bronchial epithelial cells by simulta-
neous analysis of annexin V-Cy3 staining and 7-AAD uptake
(Figure 8A). NGF-expressing cells infected with replicating rgRSV
(Figure 8B) showed a small increase in apoptosis (p,0.01) and no
change in necrosis compared to non-infected controls (p=0.80),
whereas UV-inactivated virus was again inert in terms of both
apoptosis (p=0.55) and necrosis (p=0.80). NGF-depleted cells
infected with rgRSV showed a significant increase in apoptosis
compared to the scrambled siRNA-treated infected cells (p,0.001),
whereasthe change inpercentageofnecrotic cells was notsignificant
(p=0.06). All transfected cells showed more necrosis (p,0.01)
comparedtonon-transfectedcontrols,probablyduetoanon-specific
toxic effect of the transfection medium (Lipofectamine 2000
TM).
To substantiate further our hypothesis that NGF is an
immediate response gene potentially positioned to regulate the
survival of bronchial epithelial cells during RSV infection, we
timed the early-phase cellular response to the infection monitoring
viral and NGF transcript levels by real-time PCR at hourly
Figure 1. RSV infects bronchial epithelial cells more efficiently. (A) Human nasal, tracheal, and bronchial epithelial cells after infection with
GFP-expressing RSV (rgRSV) at 1 MOI for 48 h. The bright field panels (left) show the total number of cells. The green fluorescent cells (center)
represent those which are actively infected with RSV. (B) Bronchial epithelial cells are the most susceptible to RSV infection. Flow cytometric data
show the percentage of fluorescent (infected) cells in each panel compared to the non-infected control cells (shaded histogram). Data are expressed
as the mean6SEM (n=4 experiments). ***=p,0.001 compared to nasal or tracheal cells.
doi:10.1371/journal.pone.0006444.g001
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Figures 9A and 9B confirm that bronchial cells respond with an
immediate and persistent upregulation of NGF expression during
the early phase of the RSV infection.
Discussion
The present study suggests that among cell lines derived from
the human respiratory tract, bronchial epithelial cells are
especially prone to RSV infection compared to nasal and tracheal
epithelial cells. This tropism may derive from the fact that NGF is
strongly and rapidly upregulated in bronchial cells invaded by
RSV, and may represent for these cells an essential autocrine and/
or paracrine survival factor deployed early during the infection to
prevent or delay apoptotic cell death caused by the virus.
Furthermore, consistent with our previous studies in vivo [9], UV
inactivation of the viral nucleic acid hindered the effect of RSV on
both NGF upregulation and apoptotic cell death, indicating that
the changes observed in the neurotrophin pathways are linked to
active viral replication and expression of the viral genome in the
Figure 2. RSV infection modulates NGF expression. (A) RSV-induced NGF overexpression in human bronchial epithelial cells infected for 48 h.
Cells were incubated with rabbit polyclonal NGF antibody for 1 h and subsequently treated with a secondary PE-conjugated anti-rabbit antibody.
Nuclei were stained with TOPRO-3. Pictures were taken using a confocal microscope having a fluorescence emission of 488 nm for detection of green
fluorescent protein (GFP). (B) Changes in NGF protein expression were detected by staining rgRSV-infected or non-infected nasal, tracheal and
bronchial epithelial cells with anti-human NGF antibody or a matched isotype control (shaded histogram). Primary antibody binding was detected by
incubation with PE-conjugated goat anti-rabbit antibody. (C) Geometric mean fluorescent intensity (MFI) is presented in bar graphs. Data are
expressed as the mean6SEM (n=4 experiments). **=p,0.01 compared to non-infected controls.
doi:10.1371/journal.pone.0006444.g002
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contribution from non-viral factors released from the cells used for
the preparation of RSV suspensions.
Our data also provide the first evidence that discrete cellular
responses to RSV occur in different sections of the respiratory tract
during the infection resulting in sharply different patterns of
neurotrophin expression, and that in this context the expression of
other neurotrophic factors and receptors is affected by NGF
expression. These observations provide a critical framework for the
interpretationof in vivo animal and clinical data derived from pooled
samples obtained by airway lavage or tissue homogenization.
RSV infection
Of initial interest in this investigation was to determine how
individual cells respond to RSV infection within different
anatomical regions of the respiratory tract, and their relative
susceptibility to RSV. We selected the cell lines utilized in this
study based on the fact that RSV makes a substantial contribution
to both upper and lower respiratory tract disease in individuals of
all ages [23,24]. However, clinical evidence and in vivo animal
models support the notion that the bronchial epithelium and
associated respiratory tract is the prime target of RSV infection
[25,26]. Moreover, the epidemiological evidence from retrospec-
tive and prospective studies supports the association between early-
life RSV lower respiratory tract illness and persistent airway
inflammation and hyperreactivity.
Inoculation of the nose or eyes occurs by large particle aerosols
or direct contact, results in viral replication in the nasopharynx
with an incubation period of 4 to 5 days, and can be followed over
the next several days by spread to the lower respiratory tract
[27,28] associated with the induction and secretion of multiple
cytokines and chemokines [15]. In accordance with these
observations, we performed our experiments with cells from
distinct airway sections to reenact the initiation (nasal cells),
spreading (tracheal cells), and final stabilization (bronchial cells) of
the infection. These in vitro studies suggest that human nasal,
tracheal and bronchial epithelial cells are all susceptible to RSV,
but the infectivity increases moving towards the periphery
following a gradient that fits well the pathological and clinical
progression of RSV disease [29].
Neurotrophin expression
NGF is the prototypical member of a family of neurotrophic
factors [30], including also BDNF and the neurotrophins 3 and 4
(NT3 and NT4), which controls multiple aspects of neuronal cells
life, like survival, proliferation, differentiation, neurite growth, and
neurotransmission [11,12,31]. Two types of membrane receptors
mediate neurotrophic signaling: a) the three members of the
tropomyosin-related kinase (trk) family of receptor tyrosine kinases
trkA, trkB and trkC, which exhibit selectivity for NGF, BDNF/
NT4, and NT3 respectively; and b) the p75
NTR receptor, which is
a member of the tumor necrosis factor (TNF) receptor superfamily
Figure 3. UV-inactivated RSV does not change NGF expression. (A) Following inactivation by UV light, rgRSV lost its effect on NGF expression
in human airway epithelial cells. Changes in NGF protein expression were detected by staining UV-RSV-exposed or non-infected nasal, tracheal and
bronchial epithelial cells with anti-human NGF antibody or a matched isotype control (shaded histogram). Primary antibody binding was detected by
incubation with PE-conjugated goat anti-rabbit antibody. (B) Geometric mean fluorescent intensity (MFI) is presented in bar graphs. Data are
expressed as the mean6SEM (n=4 experiments). None of the effects was statistically significant.
doi:10.1371/journal.pone.0006444.g003
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epithelial cells; (C) bronchial epithelial cells. Confluent plates of epithelial cells were infected with 1 MOI of rgRSV; after 6 h, the excess viral
particles were removed and fresh culture medium added. Subsequently, cells were harvested at 48 h and stained with specific antibody or its
matched isotype control (shaded histogram). Cells not exposed to rgRSV were used as controls. Changes in protein expression were measured by
flow cytometry using suitable secondary antibodies conjugated with phycoerythrin (PE) or allophycocyanin (APC). Geometric mean fluorescent
intensity (MFI) is presented in bar graphs. Data are expressed as the mean6SEM (n=4 experiments). *=p,0.05; **=p,0.01; ***=p,0.001
compared to non-infected controls.
doi:10.1371/journal.pone.0006444.g004
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bind at high affinity the NGF precursor (pro-NGF) and regulate
the affinity of trkA for its cognate ligand. In addition to its
neurotrophic functions, NGF modulates the activity of multiple
non-neural cells involved in immune and inflammatory responses
[33], thus functioning as a powerful and eclectic neuro-
immunomodulator.
RSV infection or uptake by respiratory epithelial cells results in
widespread changes in cellular gene expression involving a variety
of factors, including cytokines, chemokines, cell surface molecules,
and surfactants [34]. In particular, we have shown that RSV
infection in rats increases the expression of NGF and its receptors
in lung tissues homogenates, an effect that is exquisitely age-
dependent and substantially greater in young versus older animals
[9]. Overexpression of these neurogenic factors during critical
developmental windows might potentially have long-term conse-
quences distinct from adult exposures. Similar increases in NGF,
its high-affinity receptor trkA, and the related neurotrophin BDNF
have also been found in cells recovered by lavage from the lower
airways of infants with severe RSV disease and compared to
controls without respiratory infections or infected with other
(parainfluenza, adenovirus) respiratory viruses [10].
In the present study, epithelial cells proximal to the bronchial
tree, both nasal and tracheal, did not modify their NGF expression
after being infected by RSV, and this implies that the previously
reported human data obtained by bronchoalveolar lavage [10]
reflect the activity of the distal airway epithelium. In contrast, we
were not able to identify a clear source for the increased
concentration of BDNF in RSV-infected human airways [10],
suggesting that this neurotrophin is primarily contributed by
Figure 5. RSV-induced changes in neurotrophins gene expression in (A) nasal epithelial cells; (B) tracheal epithelial cells; and (C)
bronchial epithelial cells. Cells were infected with 1 MOI of rgRSV for 24 h; then, RNA was isolated and cDNA synthesized for real-time PCR
analysis. Ct values were normalized to the housekeeping gene HPRT1. Data shown are the average of 4 independent experiments performed in
duplicate, and are presented as the mean6SEM (n=8). **=p,0.01 compared to non-infected controls.
doi:10.1371/journal.pone.0006444.g005
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6444Figure 6. NGF knock-down alters gene expression of other neurotrophins in (A) nasal epithelial cells; (B) tracheal epithelial cells;
and (C) bronchial epithelial cells. After 48 h transfection with either scrambled siRNA (SCRsiRNA) or NGF-specific siRNA (NGFsiRNA), cells were
infected with 1 MOI of rgRSV for 24 h. Each experiment included non-transfected and non-infected controls. Transcript levels were analyzed by real-
time PCR for relative changes in NGF, BDNF, trkA, trkB, and p75
NTR gene expression, and fold change was calculated by normalizing Ct values to
HPRT1. Data shown are the average of 3 independent experiments performed in duplicate, and are presented as the mean6SEM (n=6). **=p,0.01;
***=p,0.001 compared to matched non-transfected controls.
doi:10.1371/journal.pone.0006444.g006
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NTR
mRNA transcripts measured in RSV-infected rat lungs [9] must
have an inflammatory origin because infected airway cells actually
reduce the expression of this receptor. Collectively, these data
suggest that NGF may be useful as a specific biomarker of lower
respiratory tract involvement during RSV infection, and also
explain why several previous attempts to detect NGF in
nasopharyngeal samples from RSV-infected children have failed
(G. Piedimonte, unpublished observations).
Nasal and tracheal epithelial cells were more resistant to RSV
infection and had a higher expression of trkA receptor, but they
did not show any significant upregulation of NGF and only
moderate changes in BDNF and its receptors. In contrast,
bronchial epithelial cells were more susceptible to RSV infection
and also showed a significant NGF upregulation subsequent to
infection, suggesting that the availability of NGF may affect the
efficiency of RSV infection. NGF has been shown to be involved in
cell protection within the nervous and immune systems during
viral infections, and may confer resistance against other virus [35].
Thus, the possibility exists that overexpression of these neuro-
trophic factors in RSV infected cells might serve as an innate
protective mechanism, either alone or synergistically with other
neurokines and cytokines [35], which allows them to tolerate, and
maybe even exploit, potentially pathogenetic virus.
On the other hand, NGF represents an essential link between
RSV-infected epithelial cells and the dense sub-epithelial neural
networks and exerts multiple actions on immune and inflamma-
tory cells, thereby contributing to the development and amplifi-
cation of airway inflammation and hyperreactivity during and
after the infection [36]. It is possible that, in addition to the
absolute expression of individual neurotrophic factors and
receptors, the relative expression of these molecules may also
Figure 7. Apoptosis in RSV-infected bronchial epithelial cells increases after NGF knock-down. (A) Scrambled siRNA-transfected
bronchial cells infected with 1 MOI or 5 MOI of rgRSV. (B) NGF siRNA-transfected bronchial cells infected with 1 MOI or 5 MOI of rgRSV. After 24 h of
infection, cells were analyzed for apoptosis by flow cytometry with annexin V PE-conjugated antibody. The shaded portions of the histograms
represent matched isotype controls. (C) Geometric mean fluorescence intensity (MFI) in NGF-depleted cells infected with 5 MOI of rgRSV was
compared with the scrambled siRNA control. Values were subtracted from the isotype MFI and presented as mean6SEM (n=4 experiments).
**=p,0.01 compared to controls transfected with scrambled siRNA.
doi:10.1371/journal.pone.0006444.g007
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mation and remodeling.
NGF and apoptosis
NGF is known to prevent apoptosis, or programmed cell death,
of rat peritoneal mast cells through trkA [29]. TrkA stimulation
also protects monocytes by up-regulating the expression of the
anti-apoptotic Bcl-2 family members [37]. The trophic effects of
NGF depend on the relative levels of trkA and p75
NTR receptors
and their combined ability to form high-affinity sites on target
cells. On the other hand, p75
NTR signaling increases JNK, NF-kB
and ceramide expression and serves as a pro-apoptotic receptor.
In our study, analysis of the early-phase of RSV infection in
airway epithelial cells demonstrates that infected cells actively
produce NGF, express enhanced levels of trkA, and drastically
decrease p75
NTR. These adjustments protect cells from the
apoptotic effects of RSV infection without affecting necrosis,
thereby enhancing epithelial viability with a mechanism similar to
that previously described in macrophages infected with human
immunodeficiency virus (HIV) [38]. In fact, the survival of
bronchial epithelial cells was dramatically decreased when the
endogenous NGF supply was depleted by transfection with specific
siRNA prior to RSV infection. The transcripts for p75
NTR
increased remarkably in bronchial cells infected with RSV
following NGF knock-down, pointing to the fact that p75
NTR
can act as a major mediator of the signaling pathway responsible
for apoptosis of the bronchial cells [39,40,41].
The relevance of these findings is closely related to the role of
apoptosis as a host cell mechanism which, in contrast to necrosis,
limits viral replication, propagation, and inflammation [42,43].
Therefore, it is conceivable that the anti-apoptotic activity of NGF
may, especially in conditions of relative immunological weakness,
allow the persistence of low-grade RSV infection, thus providing a
plausible pathophysiologic mechanism for post-bronchiolitis asth-
ma in children and COPD in elderly adults. This hypothesis may
also have important translational implications, as the selective
Figure 8. Apoptosis vs. necrosis in RSV-infected bronchial epithelial cells after NGF knock-down. (A). Dot plots of simultaneous annexin
V and 7-aminoactinomycin D (7-AAD) staining of rgRSV-infected bronchial epithelial cells transfected with scrambled (SCR) siRNA (left) or with NGF-
specific siRNA (right). After 48 h of transfection, cells were infected with 5 MOI of rgRSV. Apoptosis and necrosis were detected by DNA labeling with
7-AAD-PE and annexin V-Cy3 respectively. Data are expressed as percentage (%) of total cells. (B). Apoptosis vs. necrosis assessed by annexin V and 7-
AAD staining followed by flow cytometry. Non-transfected controls include non-infected, rgRSV-infected, and UV-RSV-exposed cells. Data are
expressed as the mean6SEM (n=3 experiments). **=p,0.01; ***=p,0.001 compared to non-infected controls.
doi:10.1371/journal.pone.0006444.g008
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critical for the management of the chronic sequelae of RSV
infection by improving the efficiency of viral clearance.
In conclusion, our data suggest that RSV infection of the distal
(bronchial) airway epithelium, but not of the more proximal (nasal
and tracheal) sections, results in overexpression of NGF and its
trkA receptor, while the other p75
NTR receptor is markedly
downregulated. This pattern of neurotrophin expression confers
protection against virus-induced apoptosis, and its inhibition via
RNA interference amplifies programmed cell death in the infected
bronchial epithelium. The different patterns of neurotrophin
expression observed between cells of proximal and distal origin
also imply that the biological mechanisms of RSV infection need
to be carefully considered across anatomically distinct regions, as
the cellular responses to this virus are significantly different.
Pharmacologic modulation of neurotrophic factors or receptors,
for example using novel strategies based on RNA interference
methodology, may offer a promising new approach for the
management of this common respiratory infection, although
additional basic and clinical research work is needed.
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